INTRODUCTION {#S1}
============

Approximately 30% of the adult population in the United States is prehypertensive, defined as systolic blood pressure (BP) between 120--139 mmHg or diastolic BP between 80--89 mmHg ([@R1]). A primary concern in adults with prehypertension is a heightened cardiovascular disease risk. Indeed, the multivariate adjusted relative risk of an adverse cardiovascular event, such as myocardial infarction, is 3.5 times higher in individuals with prehypertension compared with their normotensive counterparts of similar age ([@R2]).

Although the precise mechanisms underlying the elevated cardiovascular risk associated with prehypertension are not fully understood, moderate elevations in blood pressure may damage vascular endothelium and disrupt endothelial cell repair. Prehypertensive individuals demonstrate significant target-organ damage of the coronary ([@R3]) and renal circulation ([@R4]). Circulating endothelial progenitor cells (EPCs) have the capacity to migrate to local sites of ischemia and endothelial damage, resist cellular apoptosis, secrete potent angiogenic growth factors, and participate in vascular repair and neovascularization ([@R5];[@R6]). Moreover, systemic transplantation of *ex vivo* expanded EPCs into the coronary artery can rescue ischemic tissue and significantly improve coronary function in patients with myocardial infarction ([@R7]). Declines in EPC bioavailability and function, including reduced colony-forming capacity and migratory activity, have been linked with accelerated atherosclerotic disease progression, poor cardiovascular disease prognosis and adverse outcomes ([@R8]--[@R10]). Thus, a potential mechanism contributing to the heightened cardiovascular risk with prehypertension may be abnormalities in EPC function.

Accordingly, the experimental aim of the present study was to determine whether prehypertension is associated with EPC dysfunction. To address this aim, we isolated EPCs from healthy normotensive and prehypertensive adults and assessed EPC colony-forming capacity, migratory activity and apoptotic susceptibility.

MATERIALS AND METHODS {#S2}
=====================

Subjects {#S3}
--------

Eighty-three subjects across the adult age range were studied: 40 normotensive \[systolic BP \< 120 mmHg and diastolic BP \< 80 mmHg\] and 43 prehypertensive (systolic BP 120--139 mmHg and/or diastolic BP 80--89 mmHg). Subjects reported for testing procedures between 8 and 11 am following an overnight fast. Prehypertension was defined according to JNC-7 guidelines ([@R11]). All subjects were non-obese and free of overt cardiovascular and metabolic disease as assessed by medical history, physical examination, and fasting blood chemistries. Men over the age of 40 years were further evaluated for clinical evidence of coronary artery disease with electrocardiograms and blood pressure at rest and during incremental exercise performed to exhaustion. All of the women were at least 1 year postmenopausal (mean: 7 ± 1 years) and had never taken or had discontinued use of hormone replacement therapy at least 1 year before the start of the study. None of the subjects smoked, were taking medications, or performed regular physical exercise for at least 6 months before the start of the study. Before participation, all of the subjects had the research study and its potential risks and benefits explained fully before providing written informed consent according to the guidelines of the University of Colorado at Boulder. All experiments conformed to the Declaration of Helsinki.

Body Composition {#S4}
----------------

Body mass was measured to the nearest 0.1 kg using a medical beam balance. Percent body fat was determined by dual-energy X-ray absorptiometry (Lunar, Madison, WI). Body mass index was calculated as weight (kilograms) divided by height (meters) squared. Minimal waist circumference was measured according to published guidelines ([@R12]).

Treadmill Exercise Test {#S5}
-----------------------

To assess aerobic fitness, subjects performed incremental treadmill exercise using a modified Balke protocol. Maximal oxygen consumption (VO~2~ max) was measured using online computer-assisted open-circuit spirometry as previously described ([@R13]).

Metabolic Measurements {#S6}
----------------------

Fasting plasma lipid and lipoprotein, glucose, and insulin concentrations were determined using conventional methods by the clinical laboratory affiliated with the University of Colorado Clinical and Translational Research Center.

EPC Isolation and Characterization {#S7}
----------------------------------

As described previously ([@R14]), circulating putative EPCs were isolated from peripheral blood by Ficoll density-gradient centrifugation (Histopaque 1077, Sigma Aldrich, St Louis, MO, USA), washed and resuspended in growth medium (Medium 199; Gibco, Grand Island, NY, USA) supplemented with 20% fetal calf serum (Gibco), penicillin (100 U/ml, Gibco), and streptomycin (100 μg/ml, Gibco). Endothelial phenotype of theses cells was confirmed by immunofluorescent staining for the uptake of DiI-ac-LDL (Biomedical Technologies Inc. Stoughton, MA, USA) and expression of VEcadherin, von Willebrand factor, CD31, and vascular endothelial growth factor receptor-2 (VEGFR-2, Invitron, Carlsbad, CA, USA).

EPC Colony-Forming Assay {#S8}
------------------------

Endothelial progenitor cell colony-forming capacity was determined as previously described by our laboratory ([@R15]). Briefly, freshly isolated mononuclear cells were plated on six-well plates coated with human fibronectin (BD Biosciences, San Jose, CA, USA) for 48 hours at 37° C. Thereafter, non-adherent cells were collected, and 5 × 10^5^ cells were replated onto 24-well fibronectin-coated plates (BD Biosciences). Growth medium was changed every 3 days, and the EPC colony-forming units (CFUs) were counted manually in four random wells on the 7^th^ day by two independent investigators blinded to sample identification. Only CFUs consisting of multiple thin, flat cells emanating from a central cluster of rounded cells were counted.

Migration Assay {#S9}
---------------

EPC migratory capacity was measured using a modified Boyden chamber ([@R15]). Non-adherent cells (4 × 10^5^) were resuspended in serum-free culture medium (Medium 199, Gibco) and loaded in the upper compartment of a 24-well modified Boyden chamber coated with fibronectin (FluoroBlok, BD Biosciences). The upper chamber was placed in the lower chamber containing culture medium supplemented with vascular endothelial growth factor (2 ng/ml) and incubated for 22 hours at 37°C. Following incubation, cells were labeled with calcein AM (Molecular Probes, Eugene, Oregon), and relative fluorescent units (RFU) of migrated cells were determined in triplicate.

Determination of Caspase-3 Activation {#S10}
-------------------------------------

Activation of caspase-3 was induced in EPCs by incubating with staurosporine (1 μmol/L) for 3 h at 37°C. Following staurosporine stimulation, cells were washed in PBS and incubated with 10 μmol biotin-ZVKD-fmk inhibitor for 1 h at 37°C. Thereafter, cells were washed and lysed with extraction buffer at a concentration of 1 × 10^7^ cells/mL. The concentration of active caspase-3 in the supernatant was determined by enzyme immunoassay (R&D Systems, Minneapolis, MN).

Statistical Analysis {#S11}
--------------------

Differences in subject baseline characteristics and the primary outcome variables were determined by analysis of variance (ANOVA). Relations between variables of interest were determined by linear regression analysis. There were no significant gender interactions in any of the primary outcome variables; therefore, the data were pooled and presented together. Data are reported as mean ± SEM. Statistical significance was set at *P*\<0.05.

RESULTS {#S12}
=======

Selected subject characteristics are presented in the [table](#T1){ref-type="table"}. Although most anthropometric characteristics were similar between the groups, percent body fat was significantly lower in the prehypertensive adults. By design, both systolic and diastolic BP were higher (*P*\<0.05) in the prehypertensive group compared with the normotensive controls. There were no differences between the groups in plasma lipid and lipoprotein, glucose, and insulin concentrations.

There were no significant differences in the number of EPC CFUs between the normotensive (10±2) and prehypertensive (9±1) groups. EPC migratory activity was also similar between the normotensive (1165±82 RFU) and prehypertensive (1120±84 RFU) adults. In addition, basal (0.3±0.04 vs. 0.3 ± 0.03 ng/mL) and stimulated (2.7±0.3 vs. 2.3±0.2 ng/mL) intracellular active caspase-3 concentrations were not different between the normotensive and prehypertensive adults. However, when the prehypertensive group was stratified into low prehypertension (n = 27; 120--129 mmHg systolic BP or 80--84 mmHg diastolic BP) and high prehypertension (n = 16; 130--139 mmHg systolic BP or 85--89 mmHg diastolic BP), differences in EPC colony-forming capacity emerged. EPCs isolated from adults with high prehypertension produced \~65% (4±1; *P*\<0.05) fewer CFUs compared with both low prehypertensive (12±2) and normotensive subjects ([Figure 1](#F1){ref-type="fig"}). There was a significant correlation (r = − 0.22) between the number of EPC CFUs and systolic BP. There were no significant differences in EPC migratory activity (1010±100 vs. 1307±139 RFU) or staurosporine-induced active intracellular caspase-3 concentrations (2.2±0.2 vs. 2.5±0.4 ng/mL) between the low and high prehypertensiv groups ([Figure 2](#F2){ref-type="fig"}).

DISCUSSION {#S13}
==========

The primary new findings of the present study are that: 1) the ability of EPCs to form colonies is impaired in prehypertensive adults with systolic BP greater than 130 mmHg; and 2) prehypertension is not associated with diminished EPC migratory capacity or increased apoptotic susceptibility. To our knowledge, this is the first study to determine the influence of prehypertension on important functional characteristics of EPCs.

Numerous epidemiological studies have reported that the risk of coronary artery disease and major vascular events progressively increases with incremental elevations in blood pressure, independent of traditional risk factors, even before the onset of overt hypertension (blood pressure ≥ 140/90 mmHg) ([@R16];[@R17]). For example, in a large cohort of the Framingham Heart Study, Vasan *et al.* ([@R18]) demonstrated a significant stepwise increase in the relative risk of myocardial infarction, stroke, and heart failure in subjects with high prehypertension (systolic BP \> 130 mmHg) compared with low prehypertensive adults. Unfortunately, limited information is available concerning the pathophysiology contributing to cardiovascular disease with blood pressure in the high prehypertensive range.

Impairments in EPC function have been reported in hypertensive adults and may contribute etiologically to the increased cardiovascular risk in this group ([@R9];[@R19]). EPC colony formation is a distinctive pattern of cell arrangement that manifests after approximately one week of culture. EPC colony-forming capacity is related to flow-mediated brachial artery vasodilation and cardiovascular risk, and is a better predictor of endothelial dysfunction than conventional cardiovascular risk factors ([@R20]). In addition, the number of colony-forming units can predict the extent of multivessel coronary artery disease (CAD) in middle-aged adults. For example, it has been suggested that for every 10 EPC colony-forming unit increase, the risk of multivessel CAD declines by 20% ([@R8]).

In the present study, EPC colony-forming capacity was significantly lower (\~65%) in prehypertensive adults with systolic BP ≥ 130 mmHg. In contrast, no differences in the number of EPC CFUs were found between the low prehypertensive (systolic BP 120--129 mmHg) and normotensive adults. In addition, we observed a modest, but significant, inverse relation (r = − 0.22) between the number of EPC CFUs and systolic BP. Although a previous investigation found no difference in EPC colony-formation between patients with essential hypertension and non hypertensive subjects, the control group included prehypertensive individuals ([@R21]), meaning potential differences in EPC function between true normotensive controls and prehypertensive/hypertensive subjects may have been obscured. Indeed, the mean colony number of our high-prehypertensive subjects is similar to the control subjects in that study (4±1 vs. 3±1). Of note, our findings support the notion that the negative influence of prehypertension on EPC function is a consequence of elevated systolic rather than diastolic blood pressure. Moreover, it is consistent with many prospective observational studies demonstrating that the deleterious cardiovascular consequences associated with prehypertension, e.g. increased risk of myocardial infarction and ischemic stroke, are attributable to elevations in systolic BP ([@R22];[@R23]).

In contrast to colony-formation, EPC migration was remarkably similar in the normotensive and prehypertensive groups, even when stratified into low and high prehypertension. The ability of EPCs to migrate is essential for homing to local sites of vascular injury and promoting revascularization and new blood vessel formation ([@R24]). For example, in patients with myocardial infarction, the reduction in infarct size following transplantation of *ex vivo* expanded progenitor cells into the coronary artery is determined by their ability to migrate to ischemic tissue ([@R25]). At sites of vascular trauma and injury, VEGF and other angiogenic cytokines such as stromal cell derived factor-1 and granulocyte colony stimulating factor are released to recruit circulating EPCs to areas of tissue repair ([@R26]). Impaired migration of EPCs may limit the number of cells available at injured areas of vascular tissue, thus attenuating their regenerative capacity. The results of the present study indicate that prehypertension does not negatively influence the capacity of EPCs to migrate. Interestingly, Vasa *et al.* demonstrated that essential hypertension is an independent predictor of impaired EPC migration ([@R9]). Thus, it appears that a blood pressure threshold exists with respect to impaired migratory function of EPCs.

The ability of EPCs to resist apoptosis is also an important functional characteristic as continual activation and recruitment of EPCs to sites of vascular damage can lead to enhanced apoptosis and attrition ([@R5]). Greater apoptosis and enhanced susceptibility to apoptotic factors could attenuate vascular repair and contribute to endothelial dysfunction and atherogenesis. Activation of caspase-3, the so-called 'executioner molecule' of apoptosis, represents cellular commitment to programmed cell death. However, we did not observe any differences in intracellular caspase-3 concentrations stimulated by staurosporine between the prehypertensive and normotensive adults.

A potential mechanism underlying reduced EPC colony formation with prehypertension is oxidative stress and/or increased angiotensin II activity. Prehypertension is associated with a pro-oxidant environment and elevations in angiotensin II ([@R27];[@R28]). Furthermore, both oxidative stress and angiotensin II have been shown to impair EPC function ([@R29]--[@R31]). For example, treatment of *ex vivo* expanded EPCs with angiotensin II was shown to accelerate cellular senescence, inactivate telomerase, and impair EPC proliferation through increased intracellular oxidative damage, while pre-treatment with the angiotensin type 1 receptor antagonist valsartan inhibited these effects ([@R30]). Thus, it is possible that elevated angiotensin II activity with prehypertension may increase intracellular oxidative stress and accelerate telomerase inactivation, which may in turn reduce EPC colony formation. This possibility, however, requires further investigation.

There are a number of experimental considerations of the present study that should be mentioned. Firstly, there is currently no clear consensus on the most appropriate criteria for the isolation, culture or quantification of EPCs, creating ambiguity when comparing and interpreting studies involving EPCs. In the present investigation, we isolated a putative EPC cell population from circulating peripheral blood mononuclear cells and then employed a short culture period to eliminate mature, adherent cell types. The remaining cells exhibit several endothelial phenotypic characteristics, including LDL uptake and expression of lectin, VEGFR-2 and CD31 ([@R32];[@R33]). It has been consistently documented that these cells participate in vasculogenesis and vascular repair ([@R33]--[@R35]), and are related to both endothelial dysfunction and cardiovascular risk ([@R10];[@R20]). Secondly, as with all cross-sectional experimental designs, we must acknowledge the possibility that genetic and/or lifestyle behaviors influenced our results. Similarly, numerous pathologic, pharmacologic and physiologic factors have been reported to influence EPC number and function. We attempted to minimize these potential confounds by studying thoroughly screened adults who were free of overt disease, non-medicated, nonsmokers, and were not physically active.

In conclusion, the results of the present study suggest that, by and large, EPC dysfunction commonly observed with hypertension is not present in the prehypertensive state. Prehypertension is associated with reduced EPC colony forming capacity but this impairment is limited to the prehypertensive state with systolic BP ≥ 130 mmHg. However, prehypertension does not exert a negative influence on EPC migration or susceptibility to apoptosis. Thus, EPC dysfunction does not appear to be a major contributor to the increased cardiovascular risk associated with prehypertension.
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###### 

Selected Subject Characteristics

  --------------------------------------------------------------------------------------
  Variable                    Normotensive\   Prehypertensive\
                              (n=40)          (n=43)
  --------------------------- --------------- ------------------------------------------
  Age, yr                     53±2            54±2

  Gender, M/F                 19/21           32/11

  Body mass, kg               76.1±2.5        78.6±1.7

  BMI, kg/m^2^                25.7±0.6        25.9±0.4

  Body fat, %                 33.5±1.6        28.2±1.3[\*](#TFN2){ref-type="table-fn"}

  Waist circumference, cm     88.3±2.2        89.7±1.4

  Systolic BP, mmHg           111±1           128±1[\*](#TFN2){ref-type="table-fn"}

  Diastolic BP, mmHg          74±1            77±1[\*](#TFN2){ref-type="table-fn"}

  V̇O~2~max, L/min             2.6±0.2         2.7±0.2

  Total cholesterol, mmol/L   5.2±0.1         5.2±0.1

  LDL-cholesterol, mmol/L     3.2±0.1         3.4±0.1

  HDL-cholesterol, mmol/L     1.4±0.1         1.3±0.1

  Triglycerides, mmol/L       1.2±0.1         1.3±0.1

  Glucose, mmol/L             5.0±0.1         5.2±0.1

  Insulin, pmol/L             31.5±3.7        34.0±3.7

  HOMA-IR                     1.1±0.1         1.3±0.2
  --------------------------------------------------------------------------------------

Values are mean±SEM. BMI: body mass index; BP: blood pressure; LDL: low-density lipoprotein; HDL: high-density lipoprotein; HOMA-IR: homeostasis model of insulin resistance.

P \< 0.05 vs. normotensive

  ----------------------------------- ----------------------------------------------------------------------------------------
   *What is known about the topic:*   

  \-                                  Prehypertension is associated with an increased risk of coronary artery disease and\
                                      acute vascular events, such as myocardial infarction and stroke.

  \-                                  Endothelial injury and dysfunction are thought to contribute to heightened the\
                                      cardiovascular risk in individuals with prehypertension.

  \-                                  Impairments in endothelial progenitor cell (EPC) function, including reduced colony-\
                                      forming capacity and migratory activity, have been linked to endothelial dysfunction,\
                                      atherosclerotic disease progression, and cardiovascular events.

   *What this study adds:*            

  \-                                  The capacity of EPCs to form colonies is impaired in prehypertensive adults with SBP\
                                      greater than 130 mmHg.

  \-                                  Prehypertension is not associated with diminished EPC migratory activity or enhanced\
                                      susceptibility to apoptotis.
  ----------------------------------- ----------------------------------------------------------------------------------------
